Hemarina
PrivateLast Round
VC Round
Feb 1, 2021
Total Funding Raised
$8.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hemarina is a biotechnology company that develops universal therapeutic oxygen carriers derived from marine origin for medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemarina Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hemarina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2021 | ||||
| VC Round | Mar 9, 2017 | ||||
| VC Round | Mar 26, 2014 | ||||
| Series B | Jul 13, 2012 | ||||
| Series A | Feb 9, 2009 |
Key People
Founding team and executive leadership
Hemarina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arkéa Capital | Series B |
| Les Business Angels des Grandes Écoles | VC Round |
| Finistère Angels | VC Round, Series B |
| Inserm Transfert | Series A, Series B |
| Armor Angels | VC Round, Series B |
| Les Business Angels des Grandes Ecoles | VC Round |
| Crédit Mutuel Innovation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 4, 4x the trailing average.
- May 16, 2026
Monthly visitors increased 32% MoM, reaching 2.5K.
Hemarina Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemarina's valuation, stock price, and market status.